
The planned breakup would separate CVS’s retail pharmacies from its insurance and pharmacy-benefit businesses, with existing shareholders owning both companies.
CVS Health plans to split into two publicly traded companies by the first half of 2028, separating its retail pharmacies from its insurance and pharmacy benefit businesses.
The insurance and pharmacy benefit manager, or PBM, company would retain the CVS Health name and be led by CEO David Joyner. The retail pharmacy business would be called CVS Pharmacy and led by Prem Shah, currently a group president at CVS Health.
Existing CVS shareholders would own shares in both companies after the split. CVS said it would announce additional leadership roles and board members later.
The planned separation follows a board review and comes amid scrutiny of PBMs, which negotiate drug prices and manage prescription benefits for insurers and employers. Critics have raised concerns about their pricing practices, market power and potential conflicts when they are owned by companies that also run insurers and pharmacies.
CVS said the split would give each company a more focused strategy and greater ability to innovate, adopt technology and improve efficiency. The company has also said it plans to combine its insurer and PBM with Oak Street Health, Signify Health and its specialty drug business.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.